
IV ketamine, Spravato and at-home ketamine are three different ways to use the same family of medicines for depression, and they differ most in FDA status, insurance coverage and how closely you are monitored. Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression and is covered by Medicare Part B and many commercial plans, which usually require prior authorization. [1][25][26] IV ketamine is used off-label and is usually self-pay, and comparison studies, mostly observational, suggest it works about as well. [4][14][28] At-home compounded ketamine has the least oversight, and the FDA has warned about it. [5] At Alpine Health & Wellness in Kalispell, MT, we provide monitored IV ketamine infusions by referral.
| IV ketamine infusion | Spravato (esketamine nasal spray) | At-home compounded ketamine (lozenges, tablets, sprays) | |
|---|---|---|---|
| FDA status for depression | Off-label; FDA-approved only for anesthesia [4] | FDA-approved for treatment-resistant depression (2019) and for depression with acute suicidal thoughts; approved as monotherapy in January 2025 [1][2][3] | Not FDA-approved for any psychiatric disorder [5] |
| Where it's given | Medical office, by IV, usually over about 40 minutes in studies [8][10] | Only in REMS-certified healthcare settings; you spray it yourself under supervision and can't take it home [1][2] | At home |
| Monitoring | Experts advise monitoring heart, blood pressure, breathing and oxygen, and suggest considering up to 2 hours; the ideal length is unknown [19] | At least 2 hours after each dose, including pulse oximetry [1] | No provider onsite [5] |
| Dosing | Adjusted to body weight, commonly 0.5 mg/kg [8][10] | Fixed doses of 56 mg or 84 mg [1] | Varies by prescriber and compounder; FDA says no safe dosing has been established for psychiatric use [5] |
| Typical schedule | Often 6 infusions over about 2 to 3 weeks in studies [7][9][10] | Twice weekly for weeks 1 to 4, weekly for weeks 5 to 8, then weekly or every 2 weeks [1] | Varies |
| Insurance | Usually self-pay [28] | Covered by Medicare Part B and many commercial plans with prior authorization [25][26] | Varies; not FDA-approved for any psychiatric use [5] |
There is no clear winner, because the two have never been tested against each other in a randomized trial. The only randomized head-to-head trial compared IV ketamine with IV esketamine, not the nasal spray, and found them similar. [30] Here is what the rest of the evidence shows.
| Study | What it compared | People | Key result |
|---|---|---|---|
| Murrough 2013 [6] | Single IV ketamine infusion vs midazolam (active placebo) | 73 | Response at 24 hours: 64% vs 28% |
| ELEKT-D, Anand 2023 [10] | IV ketamine vs electroconvulsive therapy (ECT), not industry funded | 403 | Response: 55.4% vs 41.2%; ketamine was noninferior (at least as good) to ECT |
| TRANSFORM-2, Popova 2019 [11] | Spravato plus new antidepressant vs placebo spray plus new antidepressant (Janssen funded) | 227 | Depression scores improved about 4 points more with Spravato at day 28 |
| ESCAPE-TRD, Reif 2023 [12] | Spravato vs quetiapine, both with an antidepressant (Janssen funded) | 676 | Remission at week 8: 27.1% vs 17.6% |
| Bahji 2021 meta-analysis [13] | IV ketamine trials vs esketamine trials, compared indirectly | 1,877 in 24 trials | IV ketamine showed larger response and remission effects, but trial designs differed |
| Elmosalamy 2025 meta-analysis [14] | Studies that compared IV ketamine and esketamine head to head, mostly observational | 978 in 8 studies | Similar response and remission; IV ketamine may act faster |
Two honest caveats. The FDA noted that only one of Spravato's three short-term trials met its main goal. [2] And the IV ketamine evidence comes from smaller trials. [13] In a Mayo Clinic comparison of 62 patients, response rates were similar, but people on IV ketamine reached remission faster. [15]
Ketamine's effect is often fast but short-lived without repeat treatment. [17]
An American Psychiatric Association task force has also cautioned that long-term data on ketamine's effectiveness and safety are limited. [18]
The practical point: whichever option you choose, ask about the plan after the first few weeks, because maintenance treatment is common for both.
Spravato and IV ketamine are paid for in very different ways.
At Alpine Health & Wellness, IV ketamine is self-pay. Insurance does not cover our infusions, but you can use an HSA or FSA, and CareCredit financing is available. Call us for current pricing.
At-home ketamine raises the most safety questions. In October 2023, the FDA warned patients and providers about compounded ketamine for psychiatric use. Its main points: [5]
Telehealth programs differ in how they screen and follow patients, so ask any provider how they would handle a bad reaction at home.
Both drugs cause the same kinds of side effects, usually during or shortly after a dose. The two columns below come from different kinds of studies, so they are not a head-to-head comparison.
| Side effect | Spravato vs placebo, from the label [1] | IV ketamine, community clinic data (203 patients) [23] |
|---|---|---|
| Dissociation (feeling detached or "floaty") | 41% vs 9% | 35.6% |
| Dizziness | 29% vs 8% | 45.2% |
| Nausea | 28% vs 9% | 13.3% |
| Sedation or drowsiness | 23% vs 9% | 56.4% |
| Blood pressure increase | 10% vs 3% | 44.3% met criteria for a treatment-related high reading |
Other risks to know about:
Use this to prepare questions for your provider, not to choose on your own.
Here is what IV ketamine looks like at our clinic on Timberwolf Parkway in Kalispell:
Ketamine care comes up regularly in our Google reviews, and patients often mention feeling cared for by a knowledgeable team. We see patients from Kalispell, Whitefish, Columbia Falls, Bigfork and across the Flathead Valley. Learn more in our guide to ketamine infusion therapy for depression.
Partly. Spravato, a nasal spray form called esketamine, is FDA-approved for treatment-resistant depression. [1] Ketamine itself is FDA-approved only as an anesthetic, so IV ketamine for depression is off-label. [4]
Not exactly. Standard ketamine is a 50/50 mix of two mirror-image forms of the same molecule, and esketamine is one of them. Spravato is a fixed-dose nasal spray of esketamine, while IV ketamine contains both forms and is dosed by body weight. [1]
Spravato is covered by Medicare Part B and many commercial plans, usually with prior authorization. [25][26] IV ketamine for depression usually is not, so most patients pay out of pocket. [28] At Alpine, our infusions are self-pay, and HSA, FSA and CareCredit are accepted.
It can cause temporary dissociation, a detached or dreamlike feeling. In the Spravato trials, 41% of patients reported dissociation, which happened on the day of dosing and passed. [1] That is one reason both treatments are monitored in a clinic.
It varies. After one infusion, effects often fade within about a week. [29] After a series, relapse can occur within weeks without maintenance. [7] Many people need maintenance treatment.
Call Alpine Health & Wellness in Kalispell, MT at 406-361-7421 or book a consultation online. A referral from your primary care or mental health provider is required. Learn more about our ketamine infusion therapy.
If you are in crisis or thinking about suicide, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or call 911.
This article is for general information only and is not medical advice. Compounded medications are not FDA-approved, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. No specific outcome is promised or implied. Whether any therapy is appropriate for you can only be determined by a licensed provider after an evaluation.